Unraveling the complex relationship between phenotype and genotype poses a formidable challenge for biomedical science. Despite considerable success in identifying genetic loci that contribute to quantitative variation and disease susceptibility in humans 1 , in most organisms, the causal genetic variants at loci that contribute to complex phenotypes remain unclear 2 . Finding the responsible molecular changes would allow an understanding of how phenotypic variation arises and would confirm the identity of relevant genes.
QTLs
The NIH-HS contains individuals of varying relatedness that generate population structure in the genotypes and, hence, false positive genetic associations. We evaluated two strategies for dealing with relatedness: mixed models in which the genotypic similarity matrix between individuals modeled their phenotypic correlation 12 and resampling methods to identify loci that replicate consistently across multiple QTL models fitted on subsamples of the mapping population 13 . In both strategies, QTLs were detected by haplotype association 14 .
We compared the methods by simulation to determine which best controlled the false positive rate while retaining power. Mixed models performed better than resampling when phenotypes were simulated to have a normal distribution, but the reverse was true for phenotypes that did not have a normal distribution (that is, binary phenotypes and those with a negative binomial distribution). Because these methods have different advantages, we mapped all traits with both, but we only report those QTLs detected at false discovery rate (FDR) of 10% by the method that performed best for each trait (thresholds are given in Supplementary  Table 1) . A genome scan for one phenotype (platelet aggregation) is shown ( Fig. 2) in which three loci were identified with FDR of 10%.
We identified 355 QTLs for 122 phenotypes, with a mean of 2.9 QTLs per phenotype (Supplementary Table 3 ). The number of QTLs per phenotype and the QTL effect sizes (Fig. 1e) have markedly skewed distributions, with a median effect size of 5% (mean effect size of 6.5%). Large-effect QTLs were rare: only 22 QTLs explained more than 15% of the variance. We identified 28 QTLs that explained less than 2.5% of the phenotypic variance.
The correlation between heritability and the total variance explained jointly by the detected QTLs is shown (Fig. 1f) . On average, the QTLs explained 42% of the heritable phenotypic variance. When considering QTLs mapped in other rat crosses in the Rat Genome Database, there was significant overlap with NIH-HS QTLs for the number of arterial elastic lamina ruptures, total cholesterol levels and heart weight (at a nominal P value of 0.05; Supplementary Table 4) .
We estimated the confidence intervals for QTL locations by simulating a large number of QTLs throughout the genome with various effect sizes, and we calculated the distribution of the widths of the confidence intervals as a function of their significance ( Supplementary  Fig. 2 ). The median size of the 90% confidence interval was 4.5 Mb, on average containing more than 40 genes.
Incorporation of sequence with mapping data
We investigated the extent to which our near-complete catalog of segregating sequence variants would identify genes and causative mutations. The heterogeneous stock permits a test, called merge analysis 6 , of whether a variant is responsible for phenotypic variation, under the assumption that a single imputed variant or variants on a single progenitor haplotype are causal. Because genetic variation segregates in the form of progenitor haplotypes in the heterogeneous stock, QTLs can always be explained by variation in the haplotypes. When a QTL corresponds to a single variant though, genotypic variation at that variant will explain phenotypic variation better than progenitor haplotypes. To measure whether a single variant explained a QTL, we calculated difference (d) as log P merge -log P haplotype , where log P haplotype is the maximum negative log 10 P value of the haplotype test of no association and log P merge is the maximum of all merge log 10 P values of Shown for each strain is the amount of sequence mapped to the reference, the coverage, the percent of the genome deemed inaccessible and the counts of the three classes of variants compared to the reference strain. Private variants are variants that distinguish a specified strain from all others; most of the alleles private to BN/SsN are reference alleles.
npg variants included within the QTL. Any imputed variant with a merge log 10 P value that exceeded the maximum haplotype log 10 P value was termed a candidate variant. If d was <0, then no candidate variants existed at the QTL. We investigated the characteristics of candidate variants at 343 QTLs mapped using mixed models: at 131 QTLs (38%) we identified at least 1 candidate variant (Supplementary Table 3 ). There are three ways in which focusing on these candidate variants helps identify genes at a QTL. First, we increase resolution by ruling out a causal role for the great majority of sequence variants (usually over 90%) within most QTLs. We found 28 QTLs at which only a single gene contained candidate variants (Table 3) . One example was Ctnnd2 (encoding catenin δ2) at a QTL for an anxietyrelated phenotype (Fig. 3a) . CTNND2 is a protein found in complexes with cadherin cell adhesion molecules at neuronal synapses 15 .
Another example involved a locus influencing heart weight, where, out of 82 coding genes within the QTL, only Shank2 contained candidate SNPs (Fig. 3b) . Shank2 encodes a synaptic protein 16 not previously associated with cardiovascular physiology.
Second, merge analysis identifies some candidate variants in coding regions. Those predicted to affect protein structure are more likely to be causal. Thus, we identified a potential causal nucleotide variant in a QTL for antibody recognition of CD45RC on CD4 + and CD8 + T cells (Fig. 3c) . The antibody used binds to the CD45RC isoform, which expresses a C domain, encoded by exon 6, in which we found a candidate variant changing an amino acid (p.Arg114His).
At 43 out of 91 nonsynonymous candidate variants, where similar protein structures were available 17 , we predicted the structural consequences of mutations (for a further 48 candidate variants, there were no homologies with known protein structures). Nine genes ( Table 3) contained candidate variants for which structural evidence suggested that protein structure or interactions might be altered.
An example is shown (Fig. 3d) for the protein Tbx21, encoded by a gene within a QTL influencing the proportion of CD4 + cells with high expression of CD25. Here the candidate variant changed glycine to arginine (p.Gly175Arg). The substitution with arginine could alter the DNA-binding characteristics of this protein.
The crystal structure of human ABCB10, a mitochondrial transporter induced by GATA1 during erythroid differentiation 18, 19 , is shown (Fig. 3e) . The candidate variant p.Thr233Met, predicted to influence mean red blood cell volume, mapped to a position in the protein structure where the side chain of the residue points to the center of the transporter channel (Fig. 3e) . Threonine has a polar, uncharged side chain, whereas methionine has a hydrophobic side chain, and the difference between their structures probably results in altered transporter function. 
A r t i c l e s
Third, merge analysis eliminates candidate genes at a QTL that are distant from any candidate variant. This approach confirmed a wellestablished relationship between a cluster of apolipoprotein genes at a QTL on chromosome 1 and cholesterol biosynthesis (high-density lipoprotein (HDL), low-density lipoprotein (LDL) and total cholesterol). Similarly, merge analysis identified a locus influencing platelet aggregation on chromosome 4 that harbors the von Willebrand factor gene (Vwf), encoding a key glycoprotein involved in blood coagulation.
Merge analysis also contributed to an understanding of the pathogenesis of experimental autoimmune encephalomyelitis (EAE), an autoimmune neuroinflammatory disease with clinical and pathological similarities to multiple sclerosis 20 . The major histocompatibility complex (MHC) class II region on chromosome 20 (Eae1) is known to influence EAE susceptibility. However, attempts to identify the responsible gene have had limited success. In this study, the two variants most likely to underlie the QTL effect on chromosome 20 (with the highest merge log 10 P value) were a variant in an intron of Btnl2 and a variant 274 bp upstream of RT1-Db1, both in the MHC class II region. The human ortholog of RT1-Db1, HLA-DRB1, is associated with multiple sclerosis, with risk allele HLA-DRB1*15:01 (ref. 21 ).
Single variants rarely account for NIH-HS QTL genetic effects
Unexpectedly, 212 QTLs (62%) had no candidate variant (Fig. 4a) . We considered four explanations for this observation: (i) causative variants were missing from the sequence catalog; (ii) haplotype mapping was biased toward QTLs without candidate variants; (iii) the merge analysis underestimated statistical significance compared to single-marker association analysis; and (iv) there were multiple causal variants at a single QTL.
First, causal variants may have been missed because our sequence data were incomplete. Despite LD extending over a few megabases, not all variants were tagged by a nearby variant with identical strain distribution pattern (SDP) in the founders. For example, only 50% of the structural variants were tagged by a SNP lying within 1 Mb of the variation.
However, because only a limited set of possible SDPs exist in the heterogeneous stock, we can test whether missing genotypes are responsible for the inability to detect candidate variants. We generated SDPs for all possible diallelic and triallelic variants at every locus within the 212 QTLs and tested each by merge analysis to determine how many would have been candidate variants. Only 44 QTLs had candidate diallelic variants, and 165 had diallelic or triallelic variants. Thus, if the effect for each QTL were attributable to a single diallelic variant that we had not sequenced, there would still be 168 QTLs (49%) without a candidate variant. If the effect were attributable to a diallelic or triallelic variant, the fraction would be reduced to 14%. However, triallelic SNPs are very uncommon and are therefore unlikely to explain the large number of QTLs without candidate variants.
Second, haplotype mapping might simply not be powerful enough to detect candidate variants or might be biased toward QTLs without candidate variants. We addressed the first possibility by simulation (Fig. 4a) . We report the distribution of the d values for the differences between maximum log 10 P merge and log 10 P haplotype values, where, for QTLs where candidate variants exist, d >0. When simulated QTLs arose from single causal variants, merge analysis did indeed identify candidate variants at almost all QTLs placed in random regions of the genome as well as at QTLs simulated in the same locations as the detected QTLs.
We also considered the performance of the method at QTLs where it was highly probable that a single variant was the causal variant, namely at cis-acting expression QTLs (eQTLs) 22, 23 . We tested 1,398 eQTLs detected in the hippocampus of heterogeneous stock mice 24 , finding that the merge analysis identified variants with P values that exceeded those of the haplotype-based test at 97% of QTLs (Fig. 4b) . Notably, when we carried out the same analysis on trans eQTLs, the distribution of d values was similar to that seen for the rat phenotypic QTLs (Fig. 4b) . This difference between cis and trans eQTLs was true across all log P values, indicating that the difference is not due to lower power to detect trans eQTLs.
Because mapping QTLs using haplotype analysis might bias results toward loci without candidates (a winner's curse is likely to operate), we used merge analysis to map QTLs across the genome. The two methods did not identify the same QTLs (152 were unique to the merge method), but the merge method identified 16% fewer QTLs than the haplotype method. Notably, only 9% of the mergeidentified QTLs had no candidate variants (Supplementary Fig. 3 ). Consequently, we conclude that haplotype mapping overestimates the number of QTLs without a candidate variant, whereas merge analysis underestimates the number of these QTLs. Therefore, our best estimate of the proportion of QTLs without candidate variants is obtained from combining both methods. In the set of QTLs identified by either merge or haplotype mapping, we found that 44% of QTLs could not be explained by single causal variants (compared to 62% when only the haplotype-based QTLs were considered). Thus, although a winner's curse does operate in favor of the haplotype analysis, it cannot account for all QTLs without a candidate variant.
The third explanation was that the merge analysis underestimates statistical significance. We compared the performance of the merge analysis with that of single-marker association analysis at genotyped SNPs. Across all phenotypes, r 2 correlation between log P values was 0.9; agreement was strongest for the most highly associated SNPs. This result indicates that merge analysis performs as well as SNP analysis.
Finally, we investigated the extent to which multiple variants at QTLs would account for our findings. We investigated the consequences of a variety of complex QTL architectures by simulation (Fig. 4a) . Simulating multiple causal variants on different haplotypes reduced the frequency at which any single variant exceeded the maximum haplotype log P value, although this simulated complexity was still insufficient to mimic the observed frequency of QTLs without causal variants (Fig. 4a) . Simulating irreducible haplotypic effects arising from the reconstructed haplotype mosaics in the heterogeneous stock (rather than from a selection of sequence variants) also led to fewer QTLs with candidate variants (Fig. 4a) , although, again, the simulated proportion of QTLs without variants did not match that observed with the real QTL set. Our simulations suggest that the presence of multiple causal variants at a locus accounts in part for the inability to identify candidate causal variants. 
A r t i c l e s

Concordance between species
It is often assumed that the genetic loci underlying a phenotype in one species are homologous to those underlying the same phenotype in another and that natural variation within these loci will map to the same genes [25] [26] [27] . However, there have been no genome-wide tests of this hypothesis for natural variation. Our data allowed us to examine whether genes and QTLs identified in the NIH-HS overlapped those found to underlie the same phenotypes in a mouse heterogeneous stock 10 .
In total, 38 measures were common to both studies and were mapped using the same mixed-model method. Only one measure, the ratio of CD4 + to CD8 + T cells, showed overlap (using an FDR of 10% and looking in the 90% QTL confidence interval), but this overlap was not significant (empirical P value of 0.1). We repeated the analysis using QTLs called at a lower significance threshold (20th percentile of the extreme value distribution for each measure) and expanding the width of each QTL to 8 Mb. Overlaps for eight phenotypes, only two of which were significant at an empirical P value of 0.05 (serum urea concentration and the ratio of CD4 + to CD8 + T cells), were found (Table 4) . Overall, genetic variants in orthologous genes rarely contributed to the same phenotype in the two populations.
To test whether QTL overlap existed within similar pathways, for each of the 38 measures we asked whether the same KEGG pathways were enriched for QTL-associated genes in both mouse and rat heterogeneous stocks 28 . For only one measure, the proportion of B cells in the total white blood cell population, were the same pathways enriched in both heterogeneous stocks (corrected P value < 0.05). Even at a more relaxed significance threshold of 0.05 (not corrected for multiple testing), only three measures showed the same KEGG pathways enriched in both heterogeneous stocks.
DISCUSSION
Using 1,407 outbred rats, we have mapped 122 phenotypes and identified 355 QTLs at high resolution. We have shown how combining sequence with high-resolution mapping data can lead to the immediate identification of candidate genes and, in some cases, to the identification of candidate causal variants at many QTLs. We highlight two examples here.
The locus on chromosome 10 regulating the frequency of CD25 + CD4 + T cells and the frequencies of CD4 + and CD8 + T cells has previously been shown to control CD4 + and CD8 + T cell frequencies in a cross between ACI and F344 rats 29 , both represented in the NIH-HS progenitors. The amino acid substitution at position 175 (p.Gly175Arg) of the Tbx21 protein is a very strong causal candidate in this QTL because the affected protein domain is important for DNA interactions. Tbx21 has been implicated in the genetic control of regulatory T cells 30 , a subset of T cells with high surface expression of CD25, and might indirectly regulate the frequencies of CD4 + and CD8 + T cells through the transcriptional repressor Sin3a 31, 32 .
We implicated Abcb10 in red blood cell differentiation. Evidence from mouse knockouts indicates that this gene is essential for erythropoiesis 18, 19, 33 . The p.Thr233Met alteration in Abcb10 positions a larger, bulkier residue in a protein region that is tightly packed in the open-outward conformation of ABC transporters, potentially interfering with the conformational changes that are essential for transport of the substrate.
Two noteworthy features of the genetic architecture of complex traits in the rat emerge from this study: (i) the contrast with findings from human GWAS and (ii) the fact that about half of QTLs cannot be attributed to a single causal variant. Rat and mouse heterogeneous stock experiments differ from human GWAS in two ways. In rodent GWAS, far fewer subjects are required to detect a significant effect, and fewer loci of larger effect explain more of the variance. In rats, the median proportion of heritability explained by joint QTLs is 39.1% (mean of 42.3%), and, in mice, the median proportion is 32.2% (mean of 42.0%). In humans, the mean proportion of heritability explained is often less than 10%.
One explanation for these differences is the markedly different allele frequencies in these species. Human populations are characterized by a preponderance of rare alleles (with MAF of less than 1%), whereas heterogeneous stock populations have a relatively uniform distribution of MAFs (Fig. 1c) . However, it is Figure 4 Simulation of causal variants. (a) Plotted are the differences between the maximum negative log P values for association of imputed variants and the maximum haplotype-based log P values for the rat simulated and real QTLs. In cases where there is a single causal variant at a QTL, the log P values of some imputed variants will exceed the significance values from the haplotype analysis, such that the mean of the distribution of the differences between these log P values will be greater than zero (blue histogram). The distribution observed for the phenotypic QTLs (red histogram) has a mean less than zero. The results of simulating haplotypic effects are shown in yellow, and the consequence of simulating multiple causative variants are shown in orange. (b) Plotted is a set of 1,386 cis-acting and 7,464 trans-acting eQTLs mapped in a mouse heterogeneous stock. The distribution of the differences in log P values for the cis eQTLs resembles that seen when simulating single causative variants. The distribution for the trans eQTLs is most similar to that for the phenotypic QTLs. 
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A r t i c l e s important to realize that mice and rats differ in the degree of segregating variation (in the rat NIH-HS, there are 7.2 million SNPs compared to 10.2 million in the mouse heterogeneous stock). In rats, there are 2.8 million SNPs per heterogeneous stock strain, whereas the corresponding number in the mouse heterogeneous stock is 4.4 million. In other words, total sequence variation in itself is not a critical determinant of the explanatory power of the QTLs. Furthermore, the heritabilities of homologous phenotypes in the rat NIH-HS and in heterogeneous stock mice are highly correlated (r 2 = 0.6; P = 0.0002) (Supplementary Fig. 4) , implying that the greater sequence variation in mice does not result in increased heritability. The inability to detect a single candidate variant at half of rat QTLs was unexpected. We showed that, although reliance on haplotypebased mapping can underestimate the number of QTLs without candidate variants, after taking this bias into account (by detecting QTLs with both merge and haplotype analysis), there is still a large fraction (44%) of QTLs without candidate variants. The contrast between the 44% figure and the 97% that emerged from an analysis of variants at cis eQTLs is striking. It is also notable that the findings from trans eQTLs are very similar to those obtained in the analysis of rat phenotypes (Fig. 4) , suggesting that cis eQTLs are atypical. Our simulations indicate but have not proven that, in part, multiple causal variants at single QTLs are to blame. At present, we can only conclude that single causal variants are not always responsible for the genetic signal at a QTL. Whether the lack of single causal variants at many loci is a general feature of loci influencing complex traits remains to be determined.
One simple interpretation of human GWAS is that each locus represents the presence of a single, relatively common functional variant. Our results indicate that more complex models are required. Such alternative hypotheses exist, in which, for example, multiple alleles of varying frequency at the same or closely linked loci contribute to the association signal. Identifying the correct model of genetic action is critical for finding causative variants, as incorrect assumptions about the number and mode of action of genetic variants reduce power and can lead to false positive results 34 . The extent and nature of sequence diversity may be partly responsible for the complex way that sequence variation acts at a QTL.
It was sometimes hoped that loci found in the rat could be typed and identified in humans, thus providing a cost-efficient way to find medically relevant genes. We observe some examples where the same loci act similarly in different species, the most notable example being for variation in the ratio of CD4 + to CD8 + T cells: the locus lies within the MHC in rats, humans 35 and mice 36 , and its molecular nature in mice has been identified as a deletion in the promoter of the MHC class II gene RT1-Da 36 . However, formal tests for overlap between rats and mice at the gene or pathway level yielded little that was statistically significant. Because the amount of sequence variation segregating within the two heterogeneous stock populations is relatively limited, the inability to detect shared loci may result from sampling. Also, the relatively small number of genes found for each phenotype reduces our power to detect pathways. We suspect that it is currently not possible to accurately assess overlap between the two species.
This study strengthens the rat's role as a model organism in physiology and disease. Our mapping and sequencing data provide an important resource for addressing many biomedical questions. (accessions FO181540, FO181541, FO117626, FO181542, FO117624,  FO181543, FO117625, FO117627, FO117628, FO117629, FO117630,  FO117631 and FO117632) .
URLs. Mapping data (see
ONLINE METHODS
Sequencing of heterogeneous stock founder genomes. Genome sequencing. DNA libraries for SOLiD sequencing were generated from genomic DNA from samples of the original rats that were used to create the heterogeneous stock population. Libraries were generated using standard protocols (Life Technologies) and had a median insert size of between 109 and 196 bp. All libraries were sequenced with fragment (50-bp) and paired-end (50+35-bp) runs using SOLiD 4 and SOLiD 5500 sequencers to a depth of at least 22× base coverage for each of the eight heterogeneous stock progenitors and for the LE/Stm strain, which was used to estimate error rates in comparison with hand-finished BAC sequence.
Sequence alignment. Sequence reads were mapped against contigs of the Rnor3.4 rat reference genome assembly (reference strain BN) using BurrowsWheeler Aligner (BWA) v0.5.9 (ref. 37 ) with parameters -c -l 25, -k 2 and -n 10. Alignments from different libraries of the same heterogeneous stock progenitor were combined into a single BAM file.
Variant calling. Variant calling was performed independently for each strain. SNPs and short indels (<10 bp) were called using a modified SAMtools 38 pipeline: only unambiguously mapped reads were used. Sites with coverage below 4× or over 2,000× were not used for SNP calling. Nucleotides with base quality of <30 were ignored. Duplicate reads starting at the same position and mapping to the same strand as another read were discarded as probable PCR artifacts. Each of the called alleles had to be supported by at least one read where the variant mapped within the seed part of the read (first 25 bases). Non-reference alleles called with fewer than three reads were set to missing. Variable sites with more than two alleles within one founder were set to missing. The remaining variants were considered to be homozygous non-reference alleles (frequency of the non-reference call of >2/3) or heterozygous alleles (frequency between 1/3 and 2/3); however, we set to missing the small number of heterozygote calls, as these were probably artifacts caused, for example, by unknown duplications. We later attempted to call all the missing genotypes by imputation.
Copy number variants were called using a depth-of-coverage approach implemented in DWAC-Seq v. 0.56 using default parameters. Structural variants were called using discordant-pair mapping implemented in 1-2-3-SV v. 1.0, requiring unambiguous mapping of both paired tags and at least four tag pairs per structural variant. Structural variant calls identified by these tools were merged. Prediction of the functional effect of each variant was performed by the Variant Effect Predictor (VEP 2.1) tool 39 .
We defined inaccessible regions of the heterogeneous stock rat genomes in a similar way as for mouse genomes 4 . A base was considered to be accessible if it did not overlap simple, tandem repeats or low-complexity sequence (defined by Dust, source: Ensembl release 66) and was not covered by more than 150 reads and if average mapping quality was at least 40. Nucleotide positions within 15 bp of indels were also considered to be inaccessible for SNP calling.
False positive and false negative rates. Thirteen BACs from the LE/Stm strain were sequenced using capillary methods, assembled and manually edited, producing a total of 2.1 Mb of finished sequence. BAC sequences were aligned using BLAT 40 . For each BAC, a single contiguous alignment was obtained, which was used to extract single-base changes (SNPs), short indels (1-10 bp) and structural variants (100 bp and greater). False positive and false negative rates were estimated using the 1.9 Mb of genome sequence that was syntenic between BACs and the genome assembly, excluding low-quality BAC sequence (as defined by the BAC finishing team) and inaccessible regions. False positive and false negative rates within this 1.9 Mb were estimated on the basis of the discordance between our allele calls and those in the BACs.
Low false positive rates were independently confirmed by analysis of a randomly selected subset of 96 SNPs and 96 indels using PCR-based resequencing. Oligonucleotide primers were selected to amplify 300-bp fragments around the candidate polymorphism. When amplification was successful (SNPs, 84; indels, 80), amplicons were sequenced on an Applied Biosystems ABI 3730XL sequencer using BigDye Terminator technology, and sequences were manually analyzed with PolyPhred software.
For copy number variants and structural variants, 184 variants were selected, and PCR primers were designed in such a way that the presence or absence of a PCR product (depending on the variation type) could confirm the presence of the variation. After PCR, samples were run on agarose gels and analyzed manually. Of the 184 variants, 93 gave a PCR product. Of these 93, a group of 39 variants that were predicted structural variants in the NIH-HS founders were also confirmed by PCR in BN/NHsdMcwi, indicating that these are probably assembly errors in the current reference genome (Rn3.4). Of the remaining 54 variants, 53 gave a banding pattern according to our expectation, and, in one case, the predicted variation type was not correct.
Sequence divergence. Genotypes and genome accessibility data for heterogeneous stock rats (this study) and heterogeneous stock mice 4 were used to characterize patterns of nucleotide diversity in these two panels. We partitioned each genome into non-overlapping windows such that each window contained 100 kb of accessible sequence (defined relative to the rat BN strain or mouse C57BL6 strain). The number of sequence differences per window was calculated for all windows and for all possible pairs of strains.
Low-diversity regions. We found that the spatial distribution of pairwise differences in the rat progenitors was bimodal, with modes at 0 and 150 SNPs per 100-kb window (Fig. 1b) . On the basis of this distribution, we defined a region of low nucleotide diversity between two strains as consecutive windows with nucleotide diversity below 13 SNPs per 100-kb window.
Phenotyping. Animals. The rat NIH-HS originates from a colony established in the 1980s at the NIH 3 . Since its creation, the stock has been bred using a rotational outbreeding regimen to minimize the extent of inbreeding, drift and fixation.
Phenotyping. A full description of the phenotyping protocol is given in the Supplementary Note.
All procedures were carried out in accordance with Spanish legislation on the Protection of Animals Used for Experimental and Other Scientific Purposes and the European Community's Council Directive (86/609/EEC) on this subject. The experimental protocol was approved by the Autonomous University of Barcelona ethics committee (permit CEEAH 697).
Quality control, covariate analysis and normalization of phenotypes. Phenotype data were uploaded to a database (Integrated Genotyping System) 41 in batches over the 3 years of data collection. All relevant covariates were evaluated for their effect on each measure. The final set of covariates and transformations applied to each phenotype, as well as the number of data points for each measure, is given in Supplementary Table 1 .
Genotyping. The RATDIV array was developed as a general SNP genotyping array, applicable both to the rat heterogeneous stock project and other populations of laboratory rats. Full descriptions of the development of the rat array and of the selection of the 265,551 SNPs used in this study are given in the Supplementary Note. LD analysis. LD between SNPs in the rat and mouse heterogeneous stocks was calculated using PLINK 42 from the genotypes called for the 261,684 autosomal rat SNPs and 12,226 autosomal mouse SNPs 10 . In the rat heterogeneous stock, eight regions with very high interchromosomal LD were identified and excluded from subsequent analyses (Supplementary Table 2) . Using the UCSC liftover tool 43 , we found that these regions mapped in the new rat reference genome assembly (RGSC 5.0) to the regions with which they were in high LD in the current assembly (Rnor3.4).
QTL mapping.
Reconstruction of heterogeneous stock rat genomes as mosaics of founder haplotypes. All genetic analysis was performed using R 44 . We used the R HAPPY package 14 to calculate descent probabilities from the 8 heterogeneous stock founders for each animal at each of 265,551 intermarker intervals and then averaged these probabilities over 90-kb windows, such that we eventually worked with 24,196 probability matrices. The density of the 265,000 SNPs was much greater than the density of recombinants in the heterogeneous stock, meaning that averaging did not cause any reduction in mapping resolution (most QTLs mapped to intervals over 1 Mb in length and contained more than 10 90-kb intervals).
Accounting for confounding in the heterogeneous stock. Heterogeneous stock rats with different levels of relatedness were used in this study, including, for example, siblings, half-siblings, cousins, uncles and great-uncles. This unequal genome-wide genetic similarity meant that correlations existed in the heterogeneous stock between distant markers. These long-range correlations (as opposed to short-range correlations due to physical linkage) can be responsible for false positive associations if not accounted for. We used npg two methods to control for unequal relatedness: Resample Model Averaging (as implemented in BAGPHENOTYPE 13 ) for phenotypes with a non-normal distribution and Mixed Models for phenotypes with a normal distribution. Information on the performance of the methods is given in the Supplementary Note. Because most of the phenotypes had a normal distribution and the merge analysis was run in the mixed-model framework, we present the mixed models briefly here. These models were implemented in R so that haplotype mapping could be carried out using the descent probabilities from HAPPY 14 . The model used to test for association between the ancestral haplotypes segregating at a locus L and phenotypic variation was
where y i is the phenotypic value of rat i and β c is the regression coefficient of covariate c and x ic (the value of the covariate c in rat i). Notably, the covariates include a dummy intercept term. T Ls is the deviation in phenotypic value that results from carrying one copy of a haplotype from strain s at locus L, and P Li 
Premultiplying equation (2) by A −1 gives a transformed equation
in which the variance-covariance structure of the random term A −1 (u + ε) is now proportional to a diagonal matrix and so can be fitted as a standard linear model. Thresholds and confidence intervals. Calculations of the significance thresholds (when the phenotype was analyzed with mixed models), inclusion probability thresholds (when the phenotype was analyzed by resample model averaging) and confidence intervals are described in the Supplementary Note. Incorporation of sequence into QTL mapping. Implementation of the merge analysis in the mixed-model framework. Merge analysis is a form of imputation appropriate to heterogeneous stock-type populations whose genomes are mosaics of known haplotypes. Merge analysis asks two questions at each imputed variant: is the variant associated with the phenotype? (a standard test of association), and is its association as significant as the association in the haplotype-based test in the locality of the variant? We implemented merge analysis 6 in a mixed-model framework by comparing model (2)
where V is a sequence variant in interval L and M V is the merge matrix for the variant, formed by summing those columns of P L that carry the same allele at V (each column of P L represents one founder strain). This can be computed efficiently by defining a matrix B V that encodes the columns to be merged such that M V = P V B V . This test is applied at every variable site in the catalog of single-nucleotide variants that segregate between the eight heterogeneous stock founders. From a statistical point of view, there is no difference between two variants with the same strain distribution pattern at a locus; they will give the same merge analysis result.
(1) (1)
Because models (2) and (3) are nested, the best possible fit (in terms of variance explained) is obtained with haplotype model (2). If the QTL arises from variation at a single variant V, the fit of merge model (3) for variant V will be as good as the fit of model (2), and its significance will be greater, owing to the fewer number of degrees of freedom (for a diallelic variant, there is 1 degree of freedom for the merge model compared to the 7 degrees of freedom for the haplotype model). The merge model is fitted by multiplying by A −1 .
Simulating all possible strain distribution patterns at a QTL. For each QTL lacking variants with a merge log P value exceeding the haplotype log P value, we looked for unobserved causal variants that might not have been sequenced. We simulated candidate variants with every possible SDP (127 possible SDPs for diallelic variants and 1,094 possible SDPs when allowing for 3 alleles). Simulated variants were repeated within each QTL interval.
Simulating different QTL architectures. To investigate the hypothesis that the inability to detect candidate variants by merge analysis reflected complex architecture of the QTLs, we simulated QTLs arising from a single causal variant, QTLs arising from multiple causal variants within the same locus and/or multiple causal variants at linked loci, and QTLs arising from haplotypic effects not reducible to individual variants. In all cases, the phenotypes were simulated from three components: a genetic random effect explaining 20% of phenotypic variation, uncorrelated errors explaining 75% of phenotypic variation and a single QTL explaining 5% of phenotypic variation. When multiple causal variants were simulated, each explained the same proportion of phenotypic variation (5% divided by the number of causal variants). The effect sizes calculated a posteriori could be quite different from their target values owing to correlations between the different components of the simulated phenotypes. For the simulations reported in Figure 4a , either a single causal variant was simulated or nine causal variants were simulated in three linked loci (with each locus within 2 Mb of the central locus and distant by at least 200 kb from each other locus). Alternatively, the P L probabilities were used to simulate irreducible QTLs. We analyzed each simulation by merge analysis, and, when log (P haplotype ) was between 4 and 6 (to have a similar distribution of log P values to that of the rat QTLs), we calculated d as max log (P merge ) -max log (P haplotype ). We compared the distributions of d from the different simulation sets to determine the probable genetic architecture of the QTLs.
eQTL mapping and merge analysis in the mouse heterogeneous stock. Hippocampus expression levels in 460 heterogeneous stock mice measured using 12,000 probes on the Illumina Mouse WG-6 v1 BeadArray 24 were mapped to the mouse ancestral haplotypes in the mixed-model framework. QTLs were called in the same way as for the rat QTLs but using a confidence interval of 8 Mb and a significance threshold of 4. Cis eQTLs were defined as being within 2 Mb of the beginning of the probe, and trans eQTLs were defined as being on a different chromosome than that of the probe or being more than 10 Mb away from it on the same chromosome. Merge analysis was carried out at each eQTL, and the difference between the maximum merge log P value and the maximum haplotype log P value was calculated.
Homology modeling. To assess the potential effects of mutations on protein structure, homology models of target proteins were constructed and analyzed. Amino acid sequences of target proteins were retrieved from the Ensembl or UniProt databases 45 and were analyzed using the HHPred 46 web server to identify structures with similar amino acid sequences in PDB 17 for homology modeling with MODELLER 47 . The potential locations of the mutation-affected side chains (buried or surface exposed) and effects on the structure-function relationship (for example, disturbed hydrophobic core) were evaluated manually in PyMOL (The PyMOL Molecular Graphics System, Version 1.5.0.4).
Genetic architecture. Heritability. Heritability was defined as the ratio of the genetic variance component to the sum of the variance components estimated in the null mixed model (covariates but no QTL).
QTL effect sizes and joint effect sizes. Effect sizes were defined as the ratio between the fitted sum of squares and the total sum of squares in a model with covariates and without genetic random component. Joint effect sizes were defined as the ratio between the fitted sum of squares and the total sum of squares in a model without genetic random component, including covariates and all the QTLs called for a given phenotype. Including the genetic random component would result in underestimation of most of the effect sizes because npg part of the variance would have been attributed to it. Thus, the QTL effect sizes reported are probably overestimates.
Number of genes mapping to a QTL. The number of genes mapping to each QTL confidence interval was calculated using Ensembl protein-coding genes and genes coding for microRNAs (downloaded from BioMart 48 ).
Overlap with rat genome database (RGD) QTLs and with QTLs detected in the mouse heterogeneous stock. The calculation of the overlap between RGD and rat heterogeneous stock QTLs as well as between mouse and rat heterogeneous stock QTLs is given in the Supplementary Note.
Pathway analysis for the QTLs detected in the rat and mouse heterogeneous stocks. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway terms were retrieved using the R KEGG.db package. We used INRICH 49 to find enrichment of pathways in the mouse and rat phenotypic QTLs (as defined by the 90% confidence interval) called at a low significance threshold (20th percentile of the extreme value distribution). We report the empirical and corrected P values from INRICH.
